Modeling Alzheimer’s disease stage duration: from preclinical to prodromal to dementia

Lesen Sie diesen Artikel auf Deutsch.

Takeaway

  • The pace of Alzheimer’s disease (AD) progression from preclinical to prodromal AD and AD dementia is dependent on age, ranging from 15 years at age 80 to 24 years at age 60.

Why this matters

  • Estimates of disease progression are useful to define target populations for clinical trials and inform potential participants of prognosis prior to joining studies.

Mochten Sie mehr lesen?

Möchten Sie mehr lesen?

Loggen Sie sich ein oder registrieren Sie sich, um Zugang zu allen Inhalten von Neurodiem zu erhalten.

Sie haben bereits einen Account? Einloggen

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.